Current advances and challenges in the development of Acinetobacter vaccines
W Chen - Human vaccines & immunotherapeutics, 2015 - Taylor & Francis
Acinetobacter baumannii is a major cause of healthcare-associated infections worldwide
with high morbidity and mortality. The clinical treatment of A. baumannii infections has …
with high morbidity and mortality. The clinical treatment of A. baumannii infections has …
Recent Advances in the Pursuit of an Effective Acinetobacter baumannii Vaccine
PS Gellings, AA Wilkins, LA Morici - Pathogens, 2020 - mdpi.com
Acinetobacter baumannii has been a major cause of nosocomial infections for decades. The
absence of an available vaccine coupled with emerging multidrug resistance has prevented …
absence of an available vaccine coupled with emerging multidrug resistance has prevented …
[HTML][HTML] Vaccines for Acinetobacter baumannii: thinking “out of the box”
We are indeed fortunate that modern medicine continues to offer advancements that
promise better and longer lives. Delivering on that promise depends on our ability to …
promise better and longer lives. Delivering on that promise depends on our ability to …
Mapping Global Prevalence of Acinetobacter baumannii and Recent Vaccine Development to Tackle It
Acinetobacter baumannii is a leading cause of nosocomial infections that severely threaten
public health. The formidable adaptability and resistance of this opportunistic pathogen have …
public health. The formidable adaptability and resistance of this opportunistic pathogen have …
[HTML][HTML] Development of immunization trials against Acinetobacter baumannii
Acinetobacter baumannii has recently crossed all lines once considered harmless, pushing
its way as a nosocomial pathogen. It had acquired resistance to almost all available …
its way as a nosocomial pathogen. It had acquired resistance to almost all available …
Facing the challenges of multidrug-resistant Acinetobacter baumannii: progress and prospects in the vaccine development
ABSTRACT In 2017, the World Health Organization (WHO) named A. baumannii as one of
the three antibiotic-resistant bacterial species on its list of global priority pathogens in dire …
the three antibiotic-resistant bacterial species on its list of global priority pathogens in dire …
Subunit vaccines for Acinetobacter baumannii
N Yang, X Jin, C Zhu, F Gao, Z Weng, X Du… - Frontiers in …, 2023 - frontiersin.org
Acinetobacter baumannii is a gram-negative bacterium and a crucial opportunistic pathogen
in hospitals. A. baumannii infection has become a challenging problem in clinical practice …
in hospitals. A. baumannii infection has become a challenging problem in clinical practice …
Acinetobacter baumannii subunit vaccines: recent progress and challenges
YT Lau, HS Tan - Critical reviews in microbiology, 2024 - Taylor & Francis
Acinetobacter baumannii is a Gram-negative, opportunistic pathogen that causes
nosocomial infection with a high mortality rate in immunocompromised individuals. With the …
nosocomial infection with a high mortality rate in immunocompromised individuals. With the …
Identification of Novel Vaccine Candidates against Multidrug-Resistant Acinetobacter baumannii
DG Moriel, SA Beatson, DJ Wurpel, J Lipman… - PloS one, 2013 - journals.plos.org
Acinetobacter baumannii is an emerging opportunistic bacterium associated with
nosocomial infections in intensive care units. The alarming increase in infections caused by …
nosocomial infections in intensive care units. The alarming increase in infections caused by …
Non-antibiotic prevention and treatment against Acinetobacter baumannii infection: Are vaccines and adjuvants effective strategies?
Y Hu, X Zhang, S Deng, C Yue, X Jia… - Frontiers in Microbiology, 2023 - frontiersin.org
Acinetobacter baumannii (A. baumannii) is a Gram-negative opportunistic pathogen widely
attached to the surface of medical instruments, making it one of the most common pathogens …
attached to the surface of medical instruments, making it one of the most common pathogens …